Tag Archives: intellectual property

Evidentiary, My Dear Watson; Biosig, Instruments v. Nautilus, Inc.

Posted on August 1, 2013 by Warren Woessner

This is a guest post from Ronald Schutz of Robins, Kaplan, Miller & Ciresi. In Biosig, Instruments v. Nautilus, Inc., a unanimous panel of the Federal Circuit had little trouble deducing the definiteness of the patent at issue despite a … Continue reading →

Posted in Claim Interpretation | Tagged , , , , , , , , , | Leave a comment

Complimentary Webinar: Patenting DNA

Posted on July 25, 2013 by Warren Woessner

Join Robin Chadwick and me as we untangle the web of rulings in the upcoming webinar “Patenting DNA: Why DNA is Different and What to Do About It.”  The live CLE webinar will be presented on Wednesday, August 7th at … Continue reading →

Posted in Patent Eligible Subject Matter, Webinar | Tagged , , , , , , | Leave a comment

Bosch, Ultramercial, Commil, Fresenius: All-Star Break

Posted on July 23, 2013 by Warren Woessner

A guest post from Ron Schutz of Robins, Kaplan, Miller & Ciresi The Federal Circuit goes into the symbolic half-way point of summer leading the league with a series of homerun opinions. To keep the games back gap on updates … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , | Leave a comment

Senator Leahy Urges NIH to Exercise “March-in” Rights on Myriad’s Tests

Posted on July 17, 2013 by Warren Woessner

The Bayh-Dole Act of 1980 grants universities the right to elect to take title in any patent application and patent that was made by their researchers with the support of the Government, e.g., NIH. 35 USC s. 200 et seq. This … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | 2 Comments